Articles tagged with Neurodegenerative Diseases
A new study finds that dementia incidence started to increase in England and Wales after 2008, leading to a projected increase of 40% by 2040. The number of people with dementia may reach 1.7 million, twice the current estimate of one million.
Researchers at Gladstone Institutes found that ApoE4-producing neurons release HMGB1, triggering microglial activation and neurodegeneration. Blocking HMGB1 with experimental drugs offers strong protection against APOE4-driven neurodegeneration.
A recent study found a compelling link between vitamin B12 deficiency and chronic inflammation, which can lead to various health problems. The research revealed an inverse relationship between vitamin B12 levels and inflammatory markers in humans and mice, suggesting that higher vitamin B12 levels may lower inflammatory markers.
Researchers have discovered new insights into microglia-astrocyte communication and its impact on intracerebral hemorrhage, as well as the testicular toxicity of triptolide. Additionally, a study on epicardial cells has identified key gene markers associated with cardiac regenerative therapy strategies.
Cells employ a protective mechanism to preserve orphan ribosomal proteins during heat shock, allowing for rapid recovery once the stress subsides. This study uses lattice light sheet 4D imaging and pulse labeling with HaloTag dye to visualize these processes in real-time.
A new national ALS research consortium, Access for All in ALS, has been launched with a $16.7 million NIH award. The consortium will include 34 clinical sites nationwide and generate a longitudinal biorepository linked to detailed clinical information.
Researchers found that former football players with medical and mental health conditions like depression and anxiety are at higher risk of receiving an unverified CTE diagnosis. The study highlights the need for accurate diagnoses and access to proven treatments.
Researchers at Chalmers University of Technology have shown that graphene oxide nanoflakes can reduce the accumulation of misfolded amyloid peptides in yeast cells, which are similar to human neurons affected by Alzheimer's disease. This suggests that graphene oxide may hold great potential for treating neurodegenerative diseases.
A research team has identified a link between calcium imbalances and the progression of brain damage in children with rare genetic conditions. They found that stabilizing calcium levels could be a target for new treatments to prevent further deterioration.
Researchers at UB discover that neuron-derived extracellular vesicles regulate synaptic plasticity and neuronal signalling pathways in neurodegenerative diseases. The study suggests using these vesicles as a potential treatment to reverse neurodegenerative traits.
The journal highlights the complexities of neurological injury and neurodegenerative diseases, emphasizing virtual care as a potential solution. Identifying and treating neuropsychiatric symptoms is crucial for effective rehabilitation.
Researchers identified potential therapeutic targets for Alzheimer's disease and other conditions using a new approach combining AI-driven target identification with protein phase separation analysis. The study provides insights into the role of protein phase separation in human disease and its potential as a therapeutic target.
A new three-year grant will provide specialized dementia services and supports to underserved communities in Broward County. The project aims to improve quality of life for individuals living with or at risk of Alzheimer's disease, as well as their family caregivers.
The NY Genome Center will use patient-derived stem cells models combined with functional genomics and genome engineering to shed light on the biological processes underlying bipolar disorder. The study aims to address gaps in knowledge of genetic risk for bipolar disorder and advance treatment strategies.
The new guidelines provide a framework for genetic testing and counseling, recommending comprehensive testing and gene-targeted therapies for all persons with ALS. The guidelines aim to improve access and standardize practice among neurologists and genetic counselors.
A study published by UCI researchers found that N-acetylglucosamine reduced multiple inflammation and neurodegeneration markers in patients with Multiple Sclerosis. The dietary supplement also improved neurological function in 30% of patients, suggesting a potential new treatment for the condition.
Researchers unveil a groundbreaking MRI technology that non-invasively assesses brain iron homeostasis, shedding light on its role in normal brain function, aging, and disease. The technology offers sensitivity to changes in iron mobilization capacity and can differentiate between tumor tissue and healthy tissue.
A study published in EMBO Molecular Medicine has identified the cellular processes that lead to Parkinson's disease in patients with CHCHD2 gene mutations. The research found that a specific protein, casein kinase 1 epsilon/delta (Csnk1e/d), plays a crucial role in the disease's pathogenesis.
A new AI tool assesses motor performance using finger taps, providing rapid and standardized ratings, comparable to expert neurologists. The test outperformed primary care physicians in accuracy, opening doors to evaluating other movement disorders.
Researchers at Tokyo Medical and Dental University found that mutant α-synuclein protein propagates through the brain's lymphatic system in its monomeric state before aggregating, shedding light on Parkinson's disease progression. The study suggests targeting early events may limit disease progression.
Researchers developed a new model of hereditary Alzheimer's disease in marmosets by introducing mutations into the PSEN1 gene, which causes early-onset disease in humans. The study aims to characterize and validate genetic, molecular, functional, and cognitive features of aging and Alzheimer's disease in these animals.
Scientists at CU Anschutz Medical Campus discover that long-term potentiation requires structural functions of CaMKII, not enzymatic actions. This breakthrough opens the door to therapeutic use of inhibitors targeting only CaMKII activity.
A new molecule called A11 has been found to reduce inflammation and improve memory in models of Alzheimer's disease. By targeting the genetic transcription factor PU.1, A11 suppresses inflammatory gene expression in microglia immune cells, leading to reduced neurodegeneration and improved cognition.
Researchers at the University of Sydney have developed a nanoscale optical technique to monitor protein aggregates forming in cells, which can lead to neurodegenerative diseases such as Alzheimer's and ALS. The study provides a new window into the transition of proteins from liquid to solid phase.
Scientists successfully transfer a longevity gene from naked mole rats to mice, resulting in improved health and a 4.4% increase in median lifespan. The gene enhances cellular repair and protection, reducing inflammation and cancer risk, paving the way for potential human longevity benefits.
A new study by UC San Diego researchers shows that time-restricted feeding can improve memory and reduce amyloid protein accumulation in mice with Alzheimer's disease. This approach may provide a simple and accessible way to correct circadian disruptions, which are the leading cause of nursing home placement.
A Northwestern University study reveals how the NEK1 gene mutation affects neurons, causing instability in microtubules and disrupting nuclear import. This discovery suggests anti-cancer drugs could be used to treat ALS by stabilizing microtubules.
Researchers at UC San Diego demonstrate that hematopoietic stem cell transplants can protect against multiple signs and symptoms of Alzheimer's in a mouse model of the disease. The therapy leads to enhanced microglia health, which protects against Alzheimer's pathology, including β-amyloid build-up and neuroinflammation.
Researchers at the University of Missouri have developed a new method using nanopores to advance discoveries in neuroscience and medical applications. The technique allows for real-time detection of dynamic aptamer-small molecule interactions, which can aid in understanding DNA and RNA diseases and drug discovery.
Researchers at Scripps Research have identified a unique mitochondrial protein structure, DELE1, that plays a crucial role in activating the cell's integrated stress response. This discovery could lead to the development of new therapies for age-related diseases such as neurodegeneration and cancer.
A recent study found that the cGAS/STING molecular signaling pathway plays a critical role in driving chronic inflammation and functional decline during aging. By blocking STING, researchers were able to suppress inflammatory responses and improve tissue function, leading to enhancements in spatial and associative memory.
Scientists develop a method to construct crystalline artificial steric zippers in peptide β-sheets, paving the way for novel therapeutic strategies and materials. The research utilizes metal ions to prevent aggregation and form needle-shaped crystals with specific structural characteristics.
TRIM11 protein levels decreased in Alzheimer's disease models, suggesting replenishment may improve cognitive and motor function. The study reveals that TRIM11 plays a key role in removing tau protein tangles that cause neurodegenerative diseases like AD.
Researchers from Sahmyook University found that phyllodulcin, a natural sweetener found in hydrangeas, can efficiently inhibit amyloid beta (Aβ) aggregation and dissociate its aggregates in an animal model study. The study suggests that phyllodulcin may be useful in delaying the onset and progression of Alzheimer's disease.
Researchers at the University of Virginia Health System discovered that improper calcium signaling in mitochondria accelerates chronic inflammation, leading to age-related conditions. Increasing calcium uptake in macrophages may help prevent harmful inflammation and its effects on the brain.
A new study suggests that incorporating olive oil into your diet could help reduce the risk of dying from dementia. Regular olive oil consumption was found to be associated with a 28% lower risk of fatal dementia compared to those who never or rarely consumed olive oil.
A new diet score reveals that people who follow a more sustainable diet are 25% less likely to die during a 30-year follow-up period. Plant-based foods are associated with lower risks of chronic diseases and reduced environmental impacts.
A study published in Neuron reveals that hundreds of proteins and mRNA molecules are found in the wrong place in nerve cells affected by Motor Neurone Disease, a condition that causes paralysis. The researchers found that mislocalisation affects many more proteins than first thought, especially those involved in RNA binding.
A new study published in Aging (Albany NY) suggests that prior training can rescue cognitive decline in aging by improving task performance and strengthening memory processes. The research, conducted on rats, found that prior training enhanced short-term and intermediate memory, while also enabling encoding-boosted long-term memory.
The new Clinical Research Unit will investigate autoantibodies' role in neurological disorders, focusing on diagnosis and treatment. Researchers expect innovative therapies for patients with previously suspected diseases.
Researchers have successfully visualized the three-dimensional structure of human tRNA splicing endonuclease TSEN, a crucial enzyme in tRNA maturation. The study reveals how TSEN recognizes and excises introns from precursor tRNAs, shedding light on its role in neurodegenerative disorders like pontocerebellar hypoplasia.
Researchers discovered that CLN3 is essential for lysosome biogenesis and autophagic lysosomal reformation (ALR), uncovering a novel disease mechanism in Batten disease. The loss of CLN3 impairs lysosome formation, leading to the accumulation of dysfunctional lysosomes.
ClearTau overcomes limitations of previous methods by producing Tau fibrils efficiently and consistently. This allows researchers to study the development of tauopathies and develop disease-specific therapeutics.
A new study describes an engineered approach that makes protein aggregates amenable to spatial manipulations in both budding yeast and human cells. This system allows for the export of protein aggregates from cells, potentially protecting mother cells from toxicity and contributing to a better understanding of neurodegenerative diseases.
Scientists have developed a method to engineer tubulins with precise post-translational modifications, revealing a new interplay between polyglutamylation and detyrosination. This breakthrough uncovers the tubulin code's connection to microtubule function and its regulation in cells.
A large international collaboration has identified a genetic variant associated with faster disease progression in multiple sclerosis, highlighting the need to focus on nervous system resilience and repair. The study found that individuals with two copies of the gene variant experience accelerated disability due to MS.
Research reveals liver dysfunction and alterations in the liver-brain axis are key features of Alzheimer's disease. The study highlights the importance of peripheral organs, such as the liver, in understanding the systemic aspects of the disease.
Research at Umeå University reveals unique muscle fibers in extraocular muscles are resistant to ALS and increase in proportion when other fibers decrease. This finding could lead to new treatment strategies for slowing down the disease.
Researchers at UCLA Health have discovered that estriol, a pregnancy hormone, can repair damaged myelin in the brain's cortex of mice with multiple sclerosis. This finding offers hope for developing new treatments to address the disease's progression.
Researchers at Niigata University developed a machine-learning model to predict the age of onset for spinocerebellar degeneration diseases like SCA3 and DRPLA. The model achieved higher prediction accuracy than traditional parametric survival analyses, making it a valuable tool for genetic counseling.
Researchers at HKUST created an AI-based model that uses genetic data to forecast AD risk, outperforming existing models. The deep learning model accurately classifies patients and stratifies individuals into distinct risk groups, enabling early diagnosis and intervention.
Scientists at the University of Rochester Medical Center discovered a link between Alzheimer's disease and hearing loss in mice, finding that plaque location in the brain may contribute to hearing decline. The study suggests that tracking disease progression through amyloid PET imaging could be a potential biomarker for hearing loss.
A team of scientists led by Professor Ivan Đikić and Christian Hübner identified the role of ubiquitin in regulating ER-phagy, a process involved in the degradation of the endoplasmic reticulum. This discovery sheds light on neurodegenerative diseases caused by defective FAM134B and ARL6IP1 proteins.
Researchers developed a mobile application to detect Alzheimer's and mild cognitive impairment from speech data. The app achieved high accuracy rates, demonstrating its potential as an early detection tool.
Scientists have rebuilt the complex nanomachine in the laboratory that starts autophagy, revealing its sophisticated cellular mechanism. The study's findings could help develop future drugs to treat diseases based on a faulty autophagy process.
A new study by MIT scientists shows that 40 Hz vibration can reduce levels of the hallmark Alzheimer's protein phosphorylated tau, preserve neurons, and improve motor function in mouse models. This research demonstrates a third sensory modality to increase gamma power in the brain, offering new hope for Alzheimer's treatment.
Researchers at Washington University in St. Louis have found a way to enhance glymphatic transport using focused ultrasound with microbubbles, opening new opportunities for studying brain diseases and function. The non-invasive method shows promise for potentially mitigating neurodegenerative diseases like Alzheimer's and Parkinson's.
A UNLV study found a significant correlation between 10 specific types of gut bacteria and the likelihood of developing Alzheimer's disease, with certain bacteria identified as protective or risk factors. The findings suggest that an imbalance of gut microbiota may play a role in the disorder's development.
Researchers developed a new probe to measure pH levels in cells, revealing a constant conversion rate from endosomes to lysosomes. The probe's ability to track pH changes enables faster diagnosis and potential treatments for lysosomal diseases.
Researchers at Macquarie University identified rare genetic defects in MND and FTD patients that also cause other neurodegenerative diseases. These short tandem repeat expansions are found in over 20 diseases and may contribute to neuron death.